George Sellers
Stock Analyst at Stephens & Co.
(1.16)
# 3,828
Out of 5,180 analysts
45
Total ratings
29.17%
Success rate
-3.72%
Average return
Main Sectors:
Stocks Rated by George Sellers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESTA Establishment Labs Holdings | Maintains: Overweight | $85 → $90 | $56.75 | +58.59% | 8 | Feb 25, 2026 | |
| GKOS Glaukos | Maintains: Overweight | $115 → $145 | $107.66 | +34.68% | 5 | Jan 2, 2026 | |
| TFX Teleflex | Maintains: Overweight | $275 → $290 | $119.61 | +142.45% | 9 | Aug 2, 2024 | |
| VCEL Vericel | Maintains: Overweight | $56 → $58 | $32.17 | +80.29% | 2 | Aug 2, 2024 | |
| TMDX TransMedics Group | Maintains: Overweight | $151 → $178 | $99.41 | +79.06% | 2 | Aug 2, 2024 | |
| ANIK Anika Therapeutics | Reiterates: Equal-Weight | $24 | $14.50 | +65.52% | 6 | May 29, 2024 | |
| ENOV Enovis | Initiates: Overweight | $72 | $22.75 | +216.48% | 1 | Feb 13, 2024 | |
| APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $3.69 | +35.50% | 2 | Nov 10, 2023 | |
| TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $1.34 | +1,765.67% | 4 | Sep 12, 2023 | |
| STAA STAAR Surgical Company | Reiterates: Overweight | $57 | $18.70 | +204.81% | 6 | Aug 14, 2023 |
Establishment Labs Holdings
Feb 25, 2026
Maintains: Overweight
Price Target: $85 → $90
Current: $56.75
Upside: +58.59%
Glaukos
Jan 2, 2026
Maintains: Overweight
Price Target: $115 → $145
Current: $107.66
Upside: +34.68%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275 → $290
Current: $119.61
Upside: +142.45%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56 → $58
Current: $32.17
Upside: +80.29%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151 → $178
Current: $99.41
Upside: +79.06%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $14.50
Upside: +65.52%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $22.75
Upside: +216.48%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $3.69
Upside: +35.50%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $1.34
Upside: +1,765.67%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $18.70
Upside: +204.81%